magnesium aspartate 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definition	Drug id	CAS RN
	4517	18962-61-3

Description:

Molecule	Description
Synonyms: magnesium aspartate Aspartic Acid, Magnesium (2:1) Salt magnesium hydroaspartate	Molecular weight: 288.50 Formula: C8H12MgN2O8 CLOGP: LIPINSKI: None HAC: None HDO: None TPSA: ALOGS: ROTB: None

Molecule

Description

Synonyms:

magnesium aspartate
Aspartic Acid, Magnesium (2:1) Salt
magnesium hydroaspartate

Molecular weight: 288.50
Formula: C8H12MgN2O8
CLOGP:
LIPINSKI: None
HAC: None
HDO: None
TPSA:
ALOGS:
ROTB: None

Drug dosage:

None

ADMET properties:

None

Approvals:

None

FDA Adverse Event Reporting System (Female)

Show entries

Search:

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Listless	81.70	35.10	19	2106	2841	63484056
Reduced facial expression	72.03	35.10	16	2109	1950	63484947
Apathy	60.56	35.10	19	2106	8775	63478122
Reflexes abnormal	57.02	35.10	11	2114	670	63486227
Restlessness	53.73	35.10	24	2101	29429	63457468
Head discomfort	52.69	35.10	19	2106	13396	63473501
Hypokalaemia	47.25	35.10	34	2091	103770	63383127
Affect lability	44.56	35.10	16	2109	11135	63475762
Immobile	41.58	35.10	13	2112	5930	63480967
Urinary retention	40.73	35.10	20	2105	30281	63456616

Showing 1 to 10 of 13 entries

Previous1 2Next

FDA Adverse Event Reporting System (Male)

Show entries

Search:

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Infective exacerbation of chronic obstructive airways disease	79.03	33.61	18	1548	1833	34953532
Fractional exhaled nitric oxide increased	48.76	33.61	11	1555	1071	34954294
Hypomagnesaemia	47.59	33.61	22	1544	21829	34933536
Nerve degeneration	46.07	33.61	8	1558	200	34955165
Plantar fasciitis	41.43	33.61	11	1555	2105	34953260
Sensation of foreign body	38.44	33.61	11	1555	2772	34952593
Myoglobin blood increased	37.54	33.61	11	1555	3012	34952353
Meningitis cryptococcal	35.45	33.61	10	1556	2394	34952971

Showing 1 to 8 of 8 entries

Previous1Next

FDA Adverse Event Reporting System (Geriatric)

Show entries

Search:

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Infective exacerbation of chronic obstructive airways disease	72.47	27.79	18	3398	2766	79738206
Listless	71.35	27.79	19	3397	3842	79737130
Reduced facial expression	62.65	27.79	16	3400	2749	79738223
Reflexes abnormal	50.73	27.79	11	3405	932	79740040
Apathy	48.71	27.79	19	3397	12958	79728014
Hypomagnesaemia	47.87	27.79	28	3388	46883	79694089
Head discomfort	46.66	27.79	19	3397	14483	79726489
Nerve degeneration	43.74	27.79	8	3408	283	79740689
Affect lability	40.55	27.79	16	3400	11243	79729729
Restlessness	37.80	27.79	24	3392	46468	79694504

Showing 1 to 10 of 19 entries

Previous1 2Next

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

Source	Code	Description
ATC	A12CC05	ALIMENTARY TRACT AND METABOLISM MINERAL SUPPLEMENTS OTHER MINERAL SUPPLEMENTS Magnesium

Drug Use | Suggest Off label Use Form| |View source of the data|

Show entries

Search:

Disease	Relation	SNOMED_ID	DOID
Constipation	indication	14760008	DOID:2089
Hypokalemia	indication	43339004
Indigestion	indication	162031009
Hypomagnesemia	indication	190855004
Incomplete passage of stool	indication	249515001
Hypokalemia Prevention	indication
Hyperkalemia	contraindication	14140009
Complete atrioventricular block	contraindication	27885002
Gastrointestinal ulcer	contraindication	40845000
Congenital myotonia, autosomal dominant form	contraindication	57938005

Showing 1 to 10 of 19 entries

Previous1 2Next

🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

Show entries

Search:

ID	Source
003851	NDDF
142131	RXNORM
4030488	VUID
4030488	VANDF
421128005	SNOMEDCT_US
421363009	SNOMEDCT_US
7018-07-7	SECONDARY_CAS_RN
87869	PUBCHEM_CID
C0543448	UMLSCUI
CHEMBL2109228	ChEMBL_ID

Showing 1 to 10 of 15 entries

Previous1 2Next

Pharmaceutical products:

Show entries

Search:

Product	Category	Ingredients	NDC	Form	Quantity	Route	Marketing	Label
Dermamed Nutrition for troubled skin	HUMAN OTC DRUG LABEL	7	69711-687	CAPSULE, GELATIN COATED	50 mg	ORAL	OTC monograph not final	10 sections

Showing 1 to 1 of 1 entries

Previous1Next